Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young Eun Chon

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
The American Journal of Gastroenterology|September 7, 2017
Reply to Huang et alYoung Eun Chon, Jun Yong Park
Clinical and Molecular Hepatology|October 15, 2024
Correspondence to editorial on "Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis"Young Eun Chon, Jung Hwan Yu, Seung Up Kim
Clinical and Molecular Hepatology|June 21, 2021
Hepatocellular carcinoma statistics in South KoreaYoung Eun Chon, Soung Won Jeong, Dae Won Jun
Journal of Gastroenterology and Hepatology|June 21, 2012
Transient elastography in real practice: a time for action?Young Eun Chon, Seung Up Kim, Sang Hoon Ahn
Clinical and Molecular Hepatology|May 30, 2024
Correspondence to editorial on "Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study"Young Eun Chon, Dong Yun Kim, Hong Jae Chon, et al.
Clinical and Molecular Hepatology|October 21, 2024
Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"Young Eun Chon, Dong Yun Kim, Hong Jae Chon, et al.
Journal of Gastroenterology and Hepatology|April 25, 2022
Gamma-glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non-alcoholic fatty liver diseaseYeonjung Ha, Young Eun Chon, Mi Na Kim, et al.
Scientific Reports|August 13, 2020
Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarateYeonjung Ha, Young Eun Chon, Mi Na Kim, et al.
European Journal of Gastroenterology & Hepatology|September 7, 2019
Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsyMi Na Kim, Ju Ho Lee, Young Eun Chon, et al.
Journal of Clinical Medicine|May 15, 2019
Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective StudyYeonjung Ha, Sohyun Hwang, Young Eun Chon, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
The American Journal of Gastroenterology|September 7, 2017
Reply to Huang et alYoung Eun Chon, Jun Yong Park
Clinical and Molecular Hepatology|October 15, 2024
Correspondence to editorial on "Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis"Young Eun Chon, Jung Hwan Yu, Seung Up Kim
Clinical and Molecular Hepatology|June 21, 2021
Hepatocellular carcinoma statistics in South KoreaYoung Eun Chon, Soung Won Jeong, Dae Won Jun
Journal of Gastroenterology and Hepatology|June 21, 2012
Transient elastography in real practice: a time for action?Young Eun Chon, Seung Up Kim, Sang Hoon Ahn
Clinical and Molecular Hepatology|May 30, 2024
Correspondence to editorial on "Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study"Young Eun Chon, Dong Yun Kim, Hong Jae Chon, et al.
Clinical and Molecular Hepatology|October 21, 2024
Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"Young Eun Chon, Dong Yun Kim, Hong Jae Chon, et al.
Journal of Gastroenterology and Hepatology|April 25, 2022
Gamma-glutamyl transpeptidase dynamics as a biomarker for advanced fibrosis in non-alcoholic fatty liver diseaseYeonjung Ha, Young Eun Chon, Mi Na Kim, et al.
Scientific Reports|August 13, 2020
Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarateYeonjung Ha, Young Eun Chon, Mi Na Kim, et al.
European Journal of Gastroenterology & Hepatology|September 7, 2019
Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsyMi Na Kim, Ju Ho Lee, Young Eun Chon, et al.
Journal of Clinical Medicine|May 15, 2019
Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective StudyYeonjung Ha, Sohyun Hwang, Young Eun Chon, et al.
Pageof 9